Free Trial

Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down - Here's What Happened

Merck KGaA logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares of Merck KGaA gapped down, opening at $127.7450 after a $133.7840 close and last trading near $125.6150, a decline of about 1.7%.
  • The stock is trading below both its 50‑day ($149.31) and 200‑day ($139.75) moving averages; the company has a market cap of roughly $16.99 billion and a P/E of 20.07.
  • Volume was very light (about 747 shares), and Merck KGaA is a long-established, family-controlled German chemical and pharmaceutical group headquartered in Darmstadt.
  • Five stocks we like better than Merck KGaA.

Merck KGaA (OTCMKTS:MKGAF - Get Free Report)'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $133.7840, but opened at $127.7450. Merck KGaA shares last traded at $125.6150, with a volume of 747 shares trading hands.

Merck KGaA Trading Down 1.7%

The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market capitalization of $16.99 billion, a price-to-earnings ratio of 20.07 and a beta of 0.96. The company has a 50-day moving average price of $149.31 and a 200-day moving average price of $139.75.

About Merck KGaA

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company's operations are organized mainly into three businesses.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines